Principal Investigator
Jaime Merchan
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20241318
Clinical Trial Summary
A Phase 1/2 Open-label Study to Evaluate the Safety and Efficacy of
MK-3120 in Participants with Advanced Solid Tumors
Phase
Phase I/II
Funding Agency/Sponsor
Industrial
Disease
Prostate, Bladder, and Kidney Cancers
Contact Information
Phone Number
+1 (407) 7659589